TGTGInsighttelegram intelligenceLIVE / telegram public index
← GitHub Trends

TGINSIGHT SIMILAR POSTS

Find similar content

Source channel @githubtrending · Post #14952 · Jul 13

#go#go_interview_questions#go_practice#golang#golang_interview_questions#golang_practice#hacktoberfest#interview#interview_practice#interview_questions#learn_to_code#learning_resources You can practice and improve your Go programming skills with an interactive web platform that offers 30 coding challenges ranging from beginner to advanced levels. It provides a live code editor with syntax highlighting, instant test results, and detailed performance analytics to help you write efficient Go code. You can track your progress on leaderboards, compare your solutions with others, and learn from detailed explanations and resources for each challenge. The platform supports easy setup via web UI, GitHub Codespaces, or command line, making it convenient to prepare for Go technical interviews and boost your coding confidence. This helps you master Go concepts and get ready for real job interviews effectively. https://github.com/RezaSi/go-interview-practice

Results

2 similar posts found

Search: #drugdevelopment

当前筛选 #drugdevelopment清除筛选
Crypto M - Crypto News

@CryptoM · Post #64470 · 04/09/2026, 01:45 AM

🚀 Hong Kong's Innovative Drug Sector Gains Momentum Hong Kong's innovative drug sector is experiencing a surge, with several companies showing significant gains. According to Jin10, Ascletis Pharma (01672.HK) saw an increase of over 3%, while Hansoh Pharmaceutical (03692.HK) rose by more than 2%. Other companies such as WuXi AppTec (02359.HK) and Sihuan Pharmaceutical (00460.HK) also followed suit with upward trends. #HongKong#Pharmaceuticals#Biotech#Innovation#StockMarket#Healthcare#DrugDevelopment

Venture Village Wall 🦄

@venturevillagewall · Post #3642 · 12/21/2024, 10:23 AM

PeproMene Bio Secures $11M Round PeproMene Bio, Inc., a clinical-stage biotech firm based in Irvine, CA, has successfully raised $11 million in funding. The investment round closed on December 18, 2024, focusing on innovative therapies targeting cancers and immune disorders. More info: PeproMene Bio #Biotech#Funding#Cancer#ImmuneDisorders#California#ClinicalStage#Therapies#Investment#Healthcare#Innovation#PeproMeneBio#Pharmaceuticals#MedicalResearch#DrugDevelopment